ArticleInternational journal of biological sciences2024

Hypoxia-activated selectivity-improved anti-PKM2 antibody combined with prodrug TH-302 for potentiated targeting therapy in hepatocellular carcinoma.

Bo Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.